News Sentiment

688443 sentiment intelligence

Chongqing Genrix Biopharmaceutical Co., Ltd. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report RSS feed
Weighted score 50 Balanced news tone 4 relevant articles
Exchange SHH China
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 23.73 Week of 17 Jul 2026
Weighted tone 50/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

80/100 classification confidence.

Company focus 4

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

-3.9% over one week, +8.6% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

Fangda advises Genrix Bio in reaching license agreement with Cullinan Therapeutics on BCMA x CD3 Bispecific Antibody for ex-Greater China Territory

Market Reaction

Balanced read

58/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 80/100 classification
One-week reaction -3.9% Price reacting lower
Trend fit Trend inactive 8.6% over four weeks
Fair value -21.2% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 0
Neutral 4
Negative 0

Relevance

Why the article matched

Direct first
Direct company coverage 4
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Law.asia 1
BioWorld News 1
iChongqing 1
Forbes 1

Event Lens

What the news is about

Classified themes
Market update 4

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-4 of 4